Apoptosis: Induction of Apoptosis: Atm, Bax, Gpx1, Il18, Mlh1, Myc, Tnf, Tradd. Anti-apoptosis: Bcl2, Bcl2l1, Hspa1a, Prdx2. Regulation of Apoptosis: Bcl2l2, Brca1, Casp1, Casp7, Casp8, Ddit3, Mgmt. Other Genes Involved in Apoptosis: Ahr, Akt1, Bag1, Clu, Dnaja3, E2f1, Gadd45b, Nfkb1, Tnfrsf1a, Tnfsf10, Tnfsf6, Tp53. Cell Cycle: Cell Cycle Arrest: Cdkn1a, Cdkn1b, Cdkn2a, Ddit3, Gadd45a, Msh2, Rb1. Negative Regulation of the Cell Cycle: Apc, Atm, Brca1, Rb1, Tp53. Regulation of the Cell Cycle: Abl1, Bcr, Brca2, Ccnd1, Cdk4, E2f1, Fgf2, Gadd45b, Il1a, Il1b, Mdm2. Other Cell Cycle Genes: Ahr, Ccnc, Ccng1, Cdk2, Chek2 (Rad53), Cryaa, Itgb1, Mlh1, Pcna. Cell Growth and Proliferation: Chemokines and Cytokines: Ccl3, Ccl4, Csf2, Cxcl10, Gdf15, Il18, Il1a, Il1b, Il6, Lta, Mif, Tnf, Tnfsf10, Tnfsf6. Growth Factors and Receptors: Ahr, Ar, Arnt, Egfr, Erbb2, Erbb3, Erbb4, Esr1, Esr2, Fgf2, Igf1r, Igf2r, Met, Tnfrsf1a. Other Genes Related to Growth and Proliferation: Abl1, Brca1, Cdk4, Cdkn1a, Cdkn1b, Fos, Igfbp6, Mdm2, Mt3, Myc, Nfkbia, Nfkbib, Ppard, Tp53. Drug Related Transporters: Abcb1, Abcb4, Abcc1, Abcc2, Abcc3, Abcc5, Abcc6, Abcg2, Crabp1, Crat, Dpyd, Egfr, Igf2r, Mt3, Nos2, Nr1i3, Pdia3 (Grp58), Por, Rad50, Xdh. Cell Adhesion Molecules: Calr, Canx, Itga6, Itga7, Itgae, Itgb1, Itgb2, (Cd18), Itgb5. Chaperones: Bag1, Calr, Canx, Ccl3, Ccl4, CCRP (Dnajc7), Cct2, Cct3, Cct4, Cct5, Cct7, Cct8, Cryab, Cxcl10, Dnaja1, Dnaja2, Dnaja3, Dnaja4, Dnajb1, Dnajb11, Dnajb4, Dnajb5, Dnajb6, Dnajb9, Dnajc4, Dnajc5, Dnajc8, Hsp105, Hspa1a, Hspa2 (Hspt70), Hspa4, Hspa9a, Hspb1, Hspb2, Hspb3, Hspca, Hspcb, Hspd1 (Hsp60), Hspe1, RGD1560574 (Dnajb10), Serpinh1, St13, Tcp1, Tra1. DNA Repair Genes: Atm, Brca1, Brca2, Ercc1, Ercc3, Mgmt, Mlh1, Msh2, Rad23a, Rad50, Ung, Xpa, Xpc, Xrcc1. Transcription Factors and Regulators: Nuclear Receptors: Ahr, Ar, Esr1, Esr2, Nr1i2, Nr1i3, Ppard, Pparg, Rara, Rarb, Rarg, Rxra, Rxrb, Rxrg. Others: Arnt, Brca1, Brca2, Ccnc, Cdk2, Cdk4, Cdkn2a, Ddit3, E2f1, Egr1, Ercc3, Fos, Hif1a, Hod (GIIg15b), Hsf1, Kcnh8 (Elk1), LOC365510 (Relb), Myc, Myst2, Nfkb1, Ppargc1a, RGD1307189 (Nfkb2), Tp53. Drug Metabolizing Enzymes: Acyltransferases: Acat1, Chat, Cml3, Crat, Dlat, Nat1, Nat5. Methyltransferases: Comt, Hnmt, Mgmt, Nnmt, Tyms. Sulfotransferases: Chst1, Chst10, Chst2, Chst3, Chst7, Chst8, RGD1561144 (Chst5), Ste, Sult1a1, Sult1b1, Sult1c1 (Sult1a2), Sult1c2, Sult2b1, Sult4a1, Tpst2. Isomerase: Lta4h, Mif, Pdia3 (Grp58), Tbxas1, Top1, Top2a. Oxidoreductases: Acadsb, Cat, Cyp11a1, Cyp11b2, Cyp1a1, Cyp1a2, Cyp1b1, Cyp20a1, Cyp24a1, Cyp2a1, Cyp2a3a, Cyp2b15, Cyp2c, Cyp2c13, Cyp2c7 (Cyp2c39), Cyp2c70 (Cyp2c22), Cyp2d13 (Cyp2d3), Cyp2d22, Cyp2e1, Cyp2f2 (Cyp2f1), Cyp3a3, Cyp3a13 (Cyp3a9), Cyp4a12, Cyp4a22 (Cyp4a1), Cyp4b1, Cyp4f2 (Cyp4f14), Cyp7a1, Cyp7b1, Cyp8b1, Dhfr, Dia1, Dpyd, Fmo1, Fmo4, Fmo5, Gpx1, Gpx2, Gsr, Hmox1, Hmox2, Nos2, Nqo1, Por, Prdx1, Prdx2, Ptgs1, Ptgs2, Sod1, Sod2, Tbxas1, Xdh. Glutathione Peroxidases: Gpx1, Gpx2, Gsta2, Gsta3 (Gsta5), Gsta4, Gstm1, Gstm2, Gstm3, Gstm5, Gsto1, Gstp2, Gstt1, Gstt2, Mgst1. Others: Bche, Ces1, Ctps, Cyp26b1, Ephx1, Ephx2, Hat1, Hspa5, Hyou1, Maoa, Maob, Mvp, Pon3, Serpine1, Ugt1a6. |
- Parcellier A, Gurbuxani S, Schmitt E, Solary E, Garrido C. Heat shock proteins, cellular chaperones that modulate mitochondrial cell death pathways. Biochem Biophys Res Commun. 2003 May 9; 304 (3): 505-12.
- Martindale JL, Holbrook NJ. Cellular response to oxidative stress: signaling for suicide and survival. J Cell Physiol. 2002 Jul; 192 (1): 1-15.
- Dalton TP, Puga A, Shertzer HG. Induction of cellular oxidative stress by aryl hydrocarbon receptor activation. Chem Biol Interact. 2002 Sep 20; 141 (1-2): 77-95.
- Owuor ED, Kong AN. Antioxidants and oxidants regulated signal transduction pathways. Biochem Pharmacol. 2002 Sep; 64 (5-6): 765-70.
- Nelson DR, Koymans L, Kamataki T, et al (1996). P450 Superfamily: Update On New Sequences, Gene Mapping, Accession Numbers And Nomenclature. Pharmacogenetics 6:1-42.
- Gonzalez FJ, Nebert DW (1990). Evolution Of The P450 Gene Superfamily: Animal-Plant "Warfare", Molecular Drive And Human Genetic Differences In Drug Oxidation. Trends Genet 6: 182-186.
- Silverman JA. Related Articles (1999) Multidrug-Resistance Transporters. Pharm Biotechnol. 12: 353-86.
- Kaufmann FC, editor (1994). Conjugation-deconjugation in drug metabolism Sulfotransferase enzymes handbook of experimental pharmacology, Vol 112.
- Falany CN (1997) Enzymology of Human Cytosolic Sulfotransferase FASEB J 11: 206-216.
- Chang BD, Swift ME, Shen M, Fang J, Broude EV, Roninson IB, Molecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic agent, Proc Natl Acad Sci U S A 2002 Jan 8; 99(1): 389-94.
- Li J, Lee JM, Johnson JA, Microarray analysis reveals an antioxidant responsive element-driven gene set involved in conferring protection from an oxidative stress-induced apoptosis in IMR-32 cells, J Biol Chem 2002 Jan 4; 277(1): 388-94.
- Bouton CM, Hossain MA, Frelin LP, Laterra J, Pevsner J, Microarray analysis of differential gene expression in lead-exposed astrocytes, Toxicol Appl Pharmacol 2001 Oct 1; 176(1): 34-53.
- Liu J, Kadiiska MB, Liu Y, Lu T, Qu W, Waalkes MP, Stress-related gene expression in mice treated with inorganic arsenicals, Toxicol Sci 2001 Jun; 61(2): 314-20.
- Reilly TP, Bourdi M, Brady JN, Pise-Masison CA, Radonovich MF, George JW, Pohl LR, Expression profiling of acetaminophen liver toxicity in mice using microarray technology, Biochem Biophys Res Commun 2001 Mar 23; 282(1): 321-8.
- Rao L, Puschner B, Prolla TA, Gene expression profiling of low selenium status in the mouse intestine: transcriptional activation of genes linked to DNA damage, cell cycle control and oxidative stress, J Nutr 2001 Dec; 131(12): 3175-81.
- Waring JF, Ciurlionis R, Jolly RA, Heindel M, Ulrich RG, Microarray analysis of hepatotoxins in vitro reveals a correlation between gene expression profiles and mechanisms of toxicity, Toxicol Lett 2001 Mar 31; 120 (1-3): 359-68.
- Bartosiewicz M, Penn S, Buckpitt A, Applications of gene arrays in environmental toxicology: fingerprints of gene regulation associated with cadmium chloride, benzo(a)pyrene, and trichloroethylene, Environ Health Perspect 2001 Jan;109(1):71-4.
- Frueh FW, Hayashibara KC, Brown PO, Whitlock JP Jr, Use of cDNA microarrays to analyze dioxin-induced changes in human liver gene expression, Toxicol Lett 2001 Jul 6; 122(3): 189-203.
- Huang Q, Dunn RT 2nd, Jayadev S, DiSorbo O, Pack FD, Farr SB, Stoll RE, Blanchard KT, Assessment of cisplatin-induced nephrotoxicity by microarray technology, Toxicol Sci 2001 Oct; 63(2): 196-207.
- Chen H, Liu J, Merrick BA, Waalkes MP, Genetic events associated with arsenic-induced malignant transformation: applications of cDNA microarray technology, Mol Carcinog 2001 Feb; 30(2): 79-87.
- Thomas RS, Rank DR, Penn SG, Zastrow GM, Hayes KR, Pande K, Glover E, Silander T, Craven MW, Reddy JK, Jovanovich SB, Bradfield CA, Identification of toxicologically predictive gene sets using cDNA microarrays, Mol Pharmacol 2001 Dec; 60 (6): 1189-94.
- Yu Z, Ford BN, Glickman BW, Identification of genes responsive to BPDE treatment in HeLa cells using cDNA expression assays, Environ Mol Mutagen 2000; 36(3): 201-5.
- Cunningham MJ, Liang S, Fuhrman S, Seilhamer JJ, Somogyi R, Gene expression microarray data analysis for toxicology profiling, Ann N Y Acad Sci 2000; 919: 52-67.
- Karran P (2001). Mechanisms of tolerance to DNA damaging therapeutic drugs. Carcinogenesis 22: 1931-1937.
- Veldman RJ, et al. (2002) Altered sphingolipid metabolism in multidrug-resistant ovarian cancer cells is due to uncoupling of glycolipid biosynthesis in the Golgi apparatus. FASEB J. 16: 1111-1113.
- Liu YY, Han TY, Giuliano AE, and Cabot MC (2001) Ceramide glycosylation potentiates cellular multidrug resistance. FASEB J. 15: 719-730.
- Rushmore TH and Kong AN (2002) Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes. Curr. Drug Metab. 3: 481-490.
- Weinhofer I, Forss-Petter S, Zigman M, Berger J (2002) Cholesterol regulates ABCD2 expression: implications for the therapy of X-linked adrenoleukodystrophy. Hum. Mol. Genet. 11: 2701-2708.
- Dini G, et al. (2002) Overexpression of the 18 kDa and 22/24 kDa FGF-2 isoforms results in differential drug resistance and amplification potential. J. Cell. Physiol. 193: 64-72.
|